| Drug Code | Therapeutic Area | R & D progress | Remark |
| WYL-001A | Treatment of glioma, gastric cancer, etc | Preclinical | |
| WYL-001C | Treatment of diffuse large B-cell lymphoma | Preclinical | |
| WGR-002 | Prevention and treatment of atherosclerosis, hyperchole | Preclinical |
简体中文
86-10-67887855
总部地址：
公司邮箱：
86-10-67887855